What amount sold does Grannus Therapeutics, Inc. report in Form D filings?

The latest linked filings report $1.8M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Grannus Therapeutics, Inc.'s most recent SEC filing?

Grannus Therapeutics, Inc.'s most recent Form D filing was on 2024-01-12.

How many investors does Grannus Therapeutics, Inc. have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Grannus Therapeutics, Inc. offer?

Grannus Therapeutics, Inc.'s SEC Form D filings indicate debt offerings.

Grannus Therapeutics, Inc.

CIK: 0001905806·Biotechnology·INDIANAPOLIS, IN·Corporation·Founded 2020

Reported Sold

$1,750,000

Total Filings

Identified Offerings

Last Filed

Jan 12, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 12, 2024Form D — New notice

Reported sold: $800,000 · Target: $800,000

Rule 506(b)·9 investors

Jan 21, 2022Form D — New notice

Reported sold: $950,000 · Target: $1,000,000

Rule 506(b)·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,750,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John Foglesong

Related Person

Appears on 2 filings

Brian Blagg

Related Person

Appears on 2 filings

James Thompson

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 12, 2024	New	$800,000	$800,000	9
Jan 21, 2022	New	$1,000,000	$950,000	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

PAHTIA TECHNOLOGIES INC

Biotechnology

Offering target: $500,000

Filed Sep 17, 2026